MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale
1 Million Microdoses used by MindBio to create proprietary microdosing formulationMindBio scientists take delivery of GMP grade LSDLargest clinical trial repository of biometric, physiological and...
MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder
Ethics approval received for take-home LSD-Microdosing clinical trial in depressed patientsClinical trial has been approved by the Clinical Trials RegistryOne of two approved take home...
The SHINE Hope Company Launches in Chicago to Tackle the Global Mental Health Crisis
CHICAGO, IL / ACCESSWIRE / March 23, 2023 / The Shine Hope Company™ moves to Chicago and adds CEO Scott Mandell, MBA, formerly co-founder and...
Mental Health Technologies Celebrates Mental Wellness Month
At Mental Health Technologies (MHT), they bring awareness to mental health concerns daily. However, each year everyone goes from the hustle and bustle of the...
THIRA Health Opens New Adult Overnight Stay Facility for Patients
'The Retreat' in Kirkland is Surrounded by Walking Trails and a Park, Reconnecting Patients With Nature and Healthy Recreation. THIRA Health, a Bellevue, Washington-based mental...
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging...